Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyperlinked line that warns consumers about the potential dangers of a drug.

On Nov. 12, drugmakers and search-engine advertising agencies participated in about 30 presentations before the FDA. The hearing room was so crowded that most people seeking an audience seat were turned away. What did the company executives say?

ESPN Magazine devotes two well-illustrated and detailed pages on performance-enhancing drugs in a recent issue. This is a must read for every attorney who represents athletes who test positive. The article probably should not be allowed in the libraries of middle and high schools.

We are not sure of the reason, but it seems that every three months or so, a national media outlet weighs in on an old story: tainted nutritional supplements. The latest is a rehash of anecdotes with the same question: Are vitamins safe? So goes the Sept. 7 article in the Wall Street Journal headlined, “What’s Really in Supplements?”

If you have not visited the NutriSupLaw blog in a little while, you should. To celebrate the start of our fifth year, we gave the blog a makeover. Or as they say on the Web, a redesign. We think the new look does a better job of displaying blog entries and organizing our growing lists of resources, links and tags.

The confusion surrounding steroid use in professional baseball has taken another strange turn. The Associated Press and New York Times report that eight of the 104 players who tested positive for steroids in 2003 fall into another category.